Biography and Research Information
OverviewAI-generated summary
Fabio Ntagwabira's research focuses on the neurological and behavioral effects of cancer treatments, particularly chemotherapy-induced cognitive impairment in mice. His work investigates potential therapeutic interventions, such as the use of piperlongumine as a neuro-protective agent. Ntagwabira also has experience with laboratory techniques, including the combined mechanical and enzymatic dissociation of mouse brain hippocampal tissue. His scholarship metrics include an h-index of 4, with 6 total publications and 113 total citations. He has collaborated with researchers Pilar Simmons, Taurean Brown, Taylor H. McElroy, and Dr. Stephanie Byrum, all from the University of Arkansas for Medical Sciences, on multiple shared publications.
Metrics
- h-index: 4
- Publications: 6
- Citations: 118
Selected Publications
-
Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment (2022)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide (2021)
Collaboration Network
Top Collaborators
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
Similar Researchers
Based on overlapping research topics